Reading a Certificate of Analysis (COA) for Research Peptides
A Certificate of Analysis (COA) is the document that connects a bench-grade research peptide to the analytical data establishing its identity, purity, and lot history. For reproducible in vitro and animal-model work, understanding how to read and interpret a COA is foundational laboratory practice.
Identity confirmation. The first analytical section typically reports mass-spectrometry (MS) data — usually electrospray ionization MS (ESI-MS) or matrix-assisted laser desorption/ionization MS (MALDI-TOF). Confirm that the observed molecular weight matches the theoretical molecular weight calculated from the peptide sequence within instrument tolerance (typically ±0.1 Da for ESI, ±1 Da for MALDI) [1]. Discrepancies suggest oxidation, truncation, or incorrect product.
Purity by HPLC. Reversed-phase HPLC at 214 nm or 280 nm with area-percent integration is the standard purity metric. Research-grade peptides typically report ≥98% purity for in vitro work; >99% is preferred for quantitative pharmacology where minor impurities could confound dose-response analysis [2]. Examine the chromatogram for the location and intensity of impurity peaks, not just the headline number.
Counterion and net peptide content. Many synthetic peptides are isolated as trifluoroacetate (TFA) or acetate salts. The COA’s “net peptide content” specifies the fraction of vial mass that is peptide, distinct from salts, residual solvent, and bound water [3]. A 10 mg vial labeled at 85% net peptide content delivers 8.5 mg of actual peptide. This number is essential for accurate dose calculations.
Microbial and endotoxin testing. For peptides used in cell-culture work, look for residual solvent analysis (USP <467>), bioburden, and bacterial endotoxin testing (LAL assay). Endotoxin contamination can confound immunological readouts even at sub-microgram levels [4].
Lot number and analytical date. Cross-reference the lot number on the vial label with the COA. The analytical date establishes when the stability window begins; manufacturer-defined shelf life is typically 24 months from this date.
Frontier Peptide Labs publishes third-party COA reports for each lot, and a research-grade Thymosin Alpha-1 (TA1) vial is supplied with full HPLC and MS documentation for laboratory research use only.
References
- Mant CT, et al. HPLC analysis and purification of peptides. Methods Mol Biol. 2007;386:3-55. DOI: 10.1007/978-1-59745-430-8_1
- Vlieghe P, et al. Synthetic therapeutic peptides: science and market. Drug Discov Today. 2010;15(1-2):40-56. DOI: 10.1016/j.drudis.2009.10.009
- Roux S, et al. Validation of a high-performance liquid chromatography method for peptide net content determination. J Pharm Biomed Anal. 2008;47(1):17-23. DOI: 10.1016/j.jpba.2007.11.046
- Schwarz H, et al. Residual endotoxin contaminations in recombinant proteins are sufficient to activate human CD1c+ dendritic cells. PLoS One. 2014;9(12):e113840. DOI: 10.1371/journal.pone.0113840